TGF-α mediates genetic susceptibility to chronic kidney disease

Journal of the American Society of Nephrology

Volumn 22, Issue 2, 2011, Pages 327-335

  Laouari, Denise ^a   Burtin, Martine ^a   Phelep, Aurélie ^a   Martino, Carla ^a   Pillebout, Evangeline ^a   Montagutelli, Xavier ^b   Friedlander, Gérard ^a   Terzi, Fabiola ^a  

^a INSERM   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMOSOME 2; CHROMOSOME 3; CHROMOSOME 6; CHRONIC KIDNEY DISEASE; COMPUTER MODEL; CONTROLLED STUDY; DISEASE COURSE; EXCISION; GENE FREQUENCY; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HUMAN CHROMOSOME; KIDNEY FUNCTION; KIDNEY TUMOR; MOUSE; MOUSE STRAIN; NEPHRON; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 79551668029     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010040356     Document Type: Article

References (40)

1. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320: 1161-1165, 1989 (Pubitemid 19124296)
2. McClellan W, Tuttle E, Issa A: Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis 12: 285-290, 1988
3. Easterling RE: Racial factors in the incidence and causation of end-stage renal disease (ESRD). Trans Am Soc Artif Intern Organs 23: 28-33, 1977
4. Knowler WC, Bennett PH, Hamman RF, Miller M: Diabetes incidence and prevalence in Pima Indians: A 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 108: 497-505, 1978
5. Rostand SG, Kirk KA, Rutsky EA, Pate BA: Racial differences in the incidence of treatment for end-stage renal disease. N Engl J Med 306: 1276-1279, 1982 (Pubitemid 12100210)
6. Qualheim RE, Rostand SG, Kirk KA, Rutsky EA, Luke RG: Changing patterns of end-stage renal disease due to hypertension. Am J Kidney Dis 18: 336-343, 1991
7. Freedman BI, Spray BJ, Tuttle AB, Buckalew VM Jr.: The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis 21: 387-393, 1993
8. Ferguson R, Grim CE, Opgenorth TJ: A familial risk of chronic renal failure among blacks on dialysis? J Clin Epidemiol 41: 1189-1196, 1988 (Pubitemid 19036521)
9. Satko SG, Freedman BI: The importance of family history on the development of renal disease. Curr Opin Nephrol Hypertens 13: 337-341, 2004
10. Spray BJ, Atassi NG, Tuttle AB, Freedman BI: Familial risk, age at onset, and cause of end-stage renal disease in white Americans. J Am Soc Nephrol 5: 1806-1810, 1995
11. Hasstedt SJ, Atkin CL, San Juan AC Jr.: Genetic heterogeneity among kindreds with Alport syndrome. Am J Hum Genet 38: 940-953, 1986
12. Fuchshuber A, Gribouval O, Ronner V, Kroiss S, Karle S, Brandis M, Hildebrandt F: Clinical and genetic evaluation of familial steroidresponsive nephrotic syndrome in childhood. J Am Soc Nephrol 12: 374-378, 2001 (Pubitemid 32116381)
13. Fain PR, McFann KK, Taylor MR, Tison M, Johnson AM, Reed B, Schrier RW: Modifier genes play a significant role in the phenotypic expression of PKD1. Kidney Int 67: 1256-1267, 2005
14. Garrett MR, Pezzolesi MG, Korstanje R: Integrating human and rodent data to identify the genetic factors involved in chronic kidney disease. J Am Soc Nephrol 21: 398-405, 2010
15. Remuzzi G, Benigni A, Remuzzi A: Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 116: 288-296, 2006
16. Esposito C, He CJ, Striker GE, Zalups RK, Striker LJ: Nature and severity of the glomerular response to nephron reduction is strain-dependent in mice. Am J Pathol 154: 891-897, 1999 (Pubitemid 29122608)
17. Kren S, Hostetter TH: The course of the remnant kidney model in mice. Kidney Int 56: 333-337, 1999
18. Ma LJ, Fogo AB: Model of robust induction of glomerulosclerosis in mice: Importance of genetic background. Kidney Int 64: 350-355, 2003
19. Salzler HR, Griffiths R, Ruiz P, Chi L, Frey C, Marchuk DA, Rockman HA, Le TH: Hypertension and albuminuria in chronic kidney disease mapped to a mouse chromosome 11 locus. Kidney Int 72: 1226-1232, 2007
20. Pillebout E, Burtin M, Yuan HT, Briand P, Woolf AS, Friedlander G, Terzi F: Proliferation and remodeling of the peritubular microcirculation after nephron reduction: Association with the progression of renal lesions. Am J Pathol 159: 547-560, 2001
21. Lautrette A, Li S, Alili R, Sunnarborg SW, Burtin M, Lee DC, Friedlander G, Terzi F: Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: A new therapeutic approach. Nat Med 11: 867-874, 2005
22. Terzi F, Burtin M, Hekmati M, Federici P, Grimber G, Briand P, Friedlander G: Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury. J Clin Invest 106: 225-234, 2000 (Pubitemid 30483126)
23. Gharavi AG, Ahmad T, Wong RD, Hooshyar R, Vaughn J, Oller S, Frankel RZ, Bruggeman LA, D'Agati VD, Klotman PE, Lifton RP: Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3. Proc Natl Acad Sci U S A 101: 2488-2493, 2004
24. Ratelade J, Lavin TA, Muda AO, Morisset L, Mollet G, Boyer O, Chen DS, Henger A, Kretzler M, Hubner N, Théry C, Gubler MC, Montagutelli X, Antignac C, Esquivel EL: Maternal environment interacts with modifier genes to influence progression of nephrotic syndrome. J Am Soc Nephrol 19: 1491-1499, 2008
25. Schulz A, Standke D, Kovacevic L, Mostler M, Kossmehl P, Stoll M, Kreutz R: A major gene locus links early onset albuminuria with renal interstitial fibrosis in the MWF rat with polygenetic albuminuria. J Am Soc Nephrol 14: 3081-3089, 2003
26. Kottgen A, Pattaro C, Boger CA, Fuchsberger C, Olden M, Glazer NL, Parsa A, Gao X, Yang Q, Smith AV, O'Connell JR, Li M, Schmidt H, Tanaka T, Isaacs A, Ketkar S, Hwang SJ, Johnson AD, Dehghan A, Teumer A, Paré G, Atkinson EJ, Zeller T, Lohman K, Cornelis MC, Probst-Hensch NM, Kronenberg F, Tönjes A, Hayward C, Aspelund T, Eiriksdottir G, Launer LJ, Harris TB, Rampersaud E, Mitchell BD, Arking DE, Boerwinkle E, Struchalin M, Cavalieri M, Singleton A, Giallauria F, Metter J, de Boer IH, Haritunians T, Lumley T, Siscovick D, Psaty BM, Zillikens MC, Oostra BA, Feitosa M, Province M, de Andrade M, Turner ST, Schillert A, Ziegler A, Wild PS, Schnabel RB, Wilde S, Munzel TF, Leak TS, Illig T, Klopp N, Meisinger C, Wichmann HE, Koenig W, Zgaga L, Zemunik T, Kolcic I, Minelli C, Hu FB, Johansson A, Igl W, Zaboli G, Wild SH, Wright AF, Campbell H, Ellinghaus D, Schreiber S, Aulchenko YS, Felix JF, Rivadeneira F, Uitterlinden AG, Hofman A, Imboden M, Nitsch D, Brandstätter A, Kollerits B, Kedenko L, Mägi R, Stumvoll M, Kovacs P, Boban M, Campbell S, Endlich K, Völzke H, Kroemer HK, Nauck M, Völker U, Polasek O, Vitart V, Badola S, Parker AN, Ridker PM, Kardia SL, Blankenberg S, Liu Y, Curhan GC, Franke A, Rochat T, Paulweber B, Prokopenko I, Wang W, Gudnason V, Shuldiner AR, Coresh J, Schmidt R, Ferrucci L, Shlipak MG, van Duijn CM, Borecki I, Krämer BK, Rudan I, Gyllensten U, Wilson JF, Witteman JC, Pramstaller PP, Rettig R, Hastie N, Chasman DI, Kao WH, Heid IM, Fox CS: New loci associated with kidney function and chronic kidney disease. Nat Genet 42: 376-384, 2010
27. Chambers JC, Zhang W, Lord GM, van der Harst P, Lawlor DA, Sehmi JS, Gale DP, Wass MN, Ahmadi KR, Bakker SJ, Beckmann J, Bilo HJ, Bochud M, Brown MJ, Caulfield MJ, Connell JM, Cook HT, Cotlarciuc I, Davey Smith G, de Silva R, Deng G, Devuyst O, Dikkeschei LD, Dimkovic N, Dockrell M, Dominiczak A, Ebrahim S, Eggermann T, Farrall M, Ferrucci L, Floege J, Forouhi NG, Gansevoort RT, Han X, Hedblad B, Homan van der Heide JJ, Hepkema BG, Hernandez-Fuentes M, Hypponen E, Johnson T, de Jong PE, Kleefstra N, Lagou V, Lapsley M, Li Y, Loos RJ, Luan J, Luttropp K, Maréchal C, Melander O, Munroe PB, Nordfors L, Parsa A, Peltonen L, Penninx BW, Perucha E, Pouta A, Prokopenko I, Roderick PJ, Ruokonen A, Samani NJ, Sanna S, Schalling M, Schlessinger D, Schlieper G, Seelen MA, Shuldiner AR, Sjögren M, Smit JH, Snieder H, Soranzo N, Spector TD, Stenvinkel P, Sternberg MJ, Swaminathan R, Tanaka T, Ubink-Veltmaat LJ, Uda M, Vollenweider P, Wallace C, Waterworth D, Zerres K, Waeber G, Wareham NJ, Maxwell PH, McCarthy MI, Jarvelin MR, Mooser V, Abecasis GR, Lightstone L, Scott J, Navis G, Elliott P, Kooner JS: Genetic loci influencing kidney function and chronic kidney disease. Nat Genet 42: 373-375, 2010
28. Osterholm AM, He B, Pitkaniemi J, Albinsson L, Berg T, Sarti C, Tuomilehto J, Tryggvason K: Genome-wide scan for type 1 diabetic nephropathy in the Finnish population reveals suggestive linkage to a single locus on chromosome 3q. Kidney Int 71: 140-145, 2007 (Pubitemid 46094687)
29. Rogus JJ, Poznik GD, Pezzolesi MG, Smiles AM, Dunn J, Walker W, Wanic K, Moczulski D, Canani L, Araki S, Makita Y, Warram JH, Krolewski AS: High-density single nucleotide polymorphism genome-wide linkage scan for susceptibility genes for diabetic nephropathy in type 1 diabetes: Discordant sibpair approach. Diabetes 57: 2519-2526, 2008
30. Karnib HH, Chua S, Gharavi AG: Genes for diabetic nephropathy: Sweet prospects on the horizon. Kidney Int 71: 94-96, 2007
31. Zeng F, Singh AB, Harris RC: The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology. Exp Cell Res 315: 602-610, 2009
32. Lowden DA, Lindemann GW, Merlino G, Barash BD, Calvet JP, Gattone VH 2nd: Renal cysts in transgenic mice expressing transforming growth factor-alpha. J Lab Clin Med 124: 386-394, 1994
33. Gattone VH 2nd, Kuenstler KA, Lindemann GW, Lu X, Cowley BD Jr., Rankin CA, Calvet JP: Renal expression of a transforming growth factor-alpha transgene accelerates the progression of inherited, slowly progressive polycystic kidney disease in the mouse. J Lab Clin Med 127: 214-222, 1996 (Pubitemid 126691000)
34. Wong RW, Kwan RW, Mak PH, Mak KK, Sham MH, Chan SY: Overexpression of epidermal growth factor induced hypospermatogenesis in transgenic mice. J Biol Chem 275: 18297-18301, 2000
35. Pillebout E, Weitzman JB, Burtin M, Martino C, Federici P, Yaniv M, Friedlander G, Terzi F: JunD protects against chronic kidney disease by regulating paracrine mitogens. J Clin Invest 112: 843-852, 2003
36. Sunnarborg SW, Hinkle CL, Stevenson M, Russell WE, Raska CS, Peschon JJ, Castner BJ, Gerhart MJ, Paxton RJ, Black RA, Lee DC: Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J Biol Chem 277: 12838-12845, 2002
37. Fernandez-Larrea J, Merlos-Suarez A, Urena JM, Baselga J, Arribas J: A role for a PDZ protein in the early secretory pathway for the targeting of proTGF-alpha to the cell surface. Mol Cell 3: 423-433, 1999 (Pubitemid 29292599)
38. Silbiger S, Neugarten J: Gender and human chronic renal disease. Gend Med 5 [Suppl A]: S3-S10, 2008
39. Neugarten J, Acharya A, Silbiger SR: Effect of gender on the progression of nondiabetic renal disease: A meta-analysis. J Am Soc Nephrol 11: 319-329, 2000
40. Yanes LL, Sartori-Valinotti JC, Reckelhoff JF: Sex steroids and renal disease: Lessons from animal studies. Hypertension 51: 976-981, 2008